Hologic Inc
HOLX58.360USD
+0.280+0.48%
Close 04/29, 16:00（ET）Quotes delayed by 15 min
13.16BMarket Cap
17.69P/E TTM
More Details of Hologic Inc Company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Company Info
Company codeHOLX
Company nameHologic Inc
IPO dateMar 01, 1990
Founded at1990
CEOMr. Stephen P. (Steve) Macmillan
Number of employees7063
Security typeOrdinary Share
Fiscal year-endMar 01
Address250 Campus Drive
CityMARLBOROUGH
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code01752
Phone15082632900
Websitehttps://www.hologic.com/
Company codeHOLX
IPO dateMar 01, 1990
Founded at1990
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen P. (Steve) Macmillan
Mr. Stephen P. (Steve) Macmillan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.22M
+7.02%
Mr. John M. Griffin
Mr. John M. Griffin
General Counsel
General Counsel
122.84K
+0.07%
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
47.34K
+4.10%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
18.81K
+11.00%
Ms. Diana De Walt
Ms. Diana De Walt
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.02K
--
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
9.93K
-34.65%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
9.26K
+25.20%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
7.06K
+15.71%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
6.16K
-1.44%
Ms. Nanaz Mohtashami
Ms. Nanaz Mohtashami
Independent Director
Independent Director
4.18K
+80.45%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen P. (Steve) Macmillan
Mr. Stephen P. (Steve) Macmillan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.22M
+7.02%
Mr. John M. Griffin
Mr. John M. Griffin
General Counsel
General Counsel
122.84K
+0.07%
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
47.34K
+4.10%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
18.81K
+11.00%
Ms. Diana De Walt
Ms. Diana De Walt
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.02K
--
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
9.93K
-34.65%
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Disposables
663.70M
64.95%
Service
198.60M
19.44%
Capital equipment, components and software
154.20M
15.09%
Other
5.30M
0.52%
By RegionUSD
Name
Revenue
Proportion
United States
757.90M
74.17%
Europe
148.90M
14.57%
Asia
59.80M
5.85%
Rest of World
55.20M
5.40%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Disposables
663.70M
64.95%
Service
198.60M
19.44%
Capital equipment, components and software
154.20M
15.09%
Other
5.30M
0.52%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
11.94%
T. Rowe Price Investment Management, Inc.
7.99%
BlackRock Institutional Trust Company, N.A.
6.08%
State Street Global Advisors (US)
4.61%
Morgan Stanley Investment Management Ltd. (UK)
3.76%
Other
65.61%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
11.94%
T. Rowe Price Investment Management, Inc.
7.99%
BlackRock Institutional Trust Company, N.A.
6.08%
State Street Global Advisors (US)
4.61%
Morgan Stanley Investment Management Ltd. (UK)
3.76%
Other
65.61%
Type
Shareholder
Proportion
Investment Advisor
53.38%
Investment Advisor/Hedge Fund
41.11%
Pension Fund
3.07%
Hedge Fund
2.62%
Research Firm
2.19%
Bank and Trust
1.72%
Sovereign Wealth Fund
0.90%
Individual Investor
0.85%
Family Office
0.05%
Institutional Shareholding
Update time: Mon, Jan 20
Update time: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1568
238.16M
106.14%
-10.52M
2024Q4
1617
238.36M
106.18%
-10.05M
2024Q3
1583
240.17M
103.42%
-3.00M
2024Q2
1580
234.77M
100.61%
-6.88M
2024Q1
1595
233.34M
99.37%
-7.61M
2023Q4
1584
235.52M
98.14%
-14.13M
2023Q3
1574
242.15M
98.88%
-13.93M
2023Q2
1583
245.52M
99.77%
-12.39M
2023Q1
1582
247.98M
100.57%
-12.56M
2022Q4
1556
249.37M
101.43%
-12.38M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
26.79M
11.94%
-54.38K
-0.20%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
17.94M
7.99%
-4.20M
-18.97%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.65M
6.08%
-23.32K
-0.17%
Dec 31, 2024
State Street Global Advisors (US)
10.35M
4.61%
-60.64K
-0.58%
Dec 31, 2024
Morgan Stanley Investment Management Ltd. (UK)
8.44M
3.76%
-455.77K
-5.12%
Dec 31, 2024
Geode Capital Management, L.L.C.
5.73M
2.55%
+144.84K
+2.59%
Dec 31, 2024
Fidelity Management & Research Company LLC
5.15M
2.29%
+82.81K
+1.64%
Dec 31, 2024
Victory Capital Management Inc.
4.92M
2.19%
+24.36K
+0.50%
Dec 31, 2024
Mitsubishi UFJ Asset Management Co., Ltd.
4.40M
1.96%
+129.03K
+3.02%
Dec 31, 2024
Pacer Advisors, Inc.
3.66M
1.63%
+3.57M
+3.88K%
Dec 31, 2024
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
2.99%
LeaderShares AlphaFactor Tactical Focused ETF
2.84%
VictoryShares THB Mid Cap ESG ETF
2.6%
Formidable ETF
2.13%
Global X US Cash Flow Kings 100 ETF
2.11%
First Trust Capital Strength ETF
1.76%
SPDR S&P Health Care Equipment ETF
1.54%
iShares U.S. Medical Devices ETF
1.53%
First Trust Health Care Alphadex Fund
1.52%
John Hancock Fundamental All Cap Core ETF
1.52%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.99%
LeaderShares AlphaFactor Tactical Focused ETF
Proportion2.84%
VictoryShares THB Mid Cap ESG ETF
Proportion2.6%
Formidable ETF
Proportion2.13%
Global X US Cash Flow Kings 100 ETF
Proportion2.11%
First Trust Capital Strength ETF
Proportion1.76%
SPDR S&P Health Care Equipment ETF
Proportion1.54%
iShares U.S. Medical Devices ETF
Proportion1.53%
First Trust Health Care Alphadex Fund
Proportion1.52%
John Hancock Fundamental All Cap Core ETF
Proportion1.52%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data